Mitchell A. Lazar
Mitchell A. Lazar
Willard and Rhoda Ware Professor of Diabetes and Metabolic Diseases, University of Pennsylvania
Verified email at pennmedicine.upenn.edu
Title
Cited by
Cited by
Year
The hormone resistin links obesity to diabetes
CM Steppan, ST Bailey, S Bhat, EJ Brown, RR Banerjee, CM Wright, ...
Nature 409 (6818), 307-312, 2001
66102001
Cofactor dynamics and sufficiency in estrogen receptor–regulated transcription
Y Shang, X Hu, J DiRenzo, MA Lazar, M Brown
Cell 103 (6), 843-852, 2000
19032000
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
CJ Phiel, F Zhang, EY Huang, MG Guenther, MA Lazar, PS Klein
Journal of Biological Chemistry 276 (39), 36734-36741, 2001
18562001
The many faces of PPARγ
M Lehrke, MA Lazar
Cell 123 (6), 993-999, 2005
14862005
Thyroid hormone receptors: multiple forms, multiple possibilities
MA Lazar
Endocrine reviews 14 (2), 184-193, 1993
12981993
Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia
F Grignani, S De Matteis, C Nervi, L Tomassoni, V Gelmetti, M Cioce, ...
Nature 391 (6669), 815-818, 1998
12651998
Resistin is an inflammatory marker of atherosclerosis in humans
MP Reilly, M Lehrke, ML Wolfe, A Rohatgi, MA Lazar, DJ Rader
Circulation 111 (7), 932-939, 2005
12472005
Forming functional fat: a growing understanding of adipocyte differentiation
AG Cristancho, MA Lazar
Nature reviews Molecular cell biology 12 (11), 722-734, 2011
11352011
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors
L Michalik, J Auwerx, JP Berger, VK Chatterjee, CK Glass, FJ Gonzalez, ...
Pharmacological reviews 58 (4), 726-741, 2006
10742006
A unified nomenclature system for the nuclear receptor superfamily
J Auwerx, E Baulieu, M Beato, M Becker-Andre, PH Burbach, G Camerino, ...
Cell 97 (2), 161-163, 1999
10371999
Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation
A Chawla, EJ Schwarz, DD Dimaculangan, MA Lazar
Endocrinology 135 (2), 798-800, 1994
10091994
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
CG Su, X Wen, ST Bailey, W Jiang, SM Rangwala, SA Keilbaugh, ...
The Journal of clinical investigation 104 (4), 383-389, 1999
9571999
A family of tissue-specific resistin-like molecules
CM Steppan, EJ Brown, CM Wright, S Bhat, RR Banerjee, CY Dai, ...
Proceedings of the National Academy of Sciences 98 (2), 502-506, 2001
9452001
Regulation of fasted blood glucose by resistin
RR Banerjee, SM Rangwala, JS Shapiro, AS Rich, B Rhoades, Y Qi, ...
Science 303 (5661), 1195-1198, 2004
9432004
Mechanisms of obesity-associated insulin resistance: many choices on the menu
M Qatanani, MA Lazar
Genes & development 21 (12), 1443-1455, 2007
9212007
New developments in adipogenesis
MI Lefterova, MA Lazar
Trends in Endocrinology & Metabolism 20 (3), 107-114, 2009
8512009
Differential activation of peroxisome proliferator-activated receptors by eicosanoids
K Yu, W Bayona, CB Kallen, HP Harding, CP Ravera, G McMahon, ...
Journal of Biological Chemistry 270 (41), 23975-23983, 1995
8461995
The mechanism of action of thyroid hormones
J Zhang, MA Lazar
Annual review of physiology 62, 2000
8272000
Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR
W Fischle, F Dequiedt, MJ Hendzel, MG Guenther, MA Lazar, W Voelter, ...
Molecular cell 9 (1), 45-57, 2002
8262002
Resistin and obesity-associated insulin resistance
CM Steppan, MA Lazar
Trends in endocrinology & Metabolism 13 (1), 18-23, 2002
7732002
The system can't perform the operation now. Try again later.
Articles 1–20